Zoely ir nākamās paaudzes kombinētās orālās kontracepcijas tabletes, kas atšķiras no tradicionālajām tabletēm, izmantojot "ķermenim identiskas" hormonus. Tajās ir estradiols, estrogēns, kas strukturāli ir identisks hormonam, ko dabiski ražo jūsu olnīcas, apvienojumā ar nomegestrola acetātu.

Šī unikālā sastāva dēļ Zoely bieži izraksta sievietēm, kuras piedzīvo blakusparādības ar sintētiskajiem estrogēniem. Tas seko nepārtrauktam 28 dienu ciklam (24 aktīvas baltas tabletes un 4 neaktīvas dzeltenas tabletes). Šī shēma palīdz uzturēt stabilu hormonu līmeni un parasti noved pie īsākām, vieglākām atkāpšanās asiņošanām vai dažkārt vispār bez asiņošanas.

Active tablets (White): Nomegestrol acetate (2.5 mg) and Estradiol hemihydrate (1.5 mg). Inactive tablets (Yellow): Placebo (contain no active substances). Excipients: Lactose monohydrate, microcrystalline cellulose, crospovidone, talc, magnesium stearate, colloidal anhydrous silica.

Nausea, headaches, breast tenderness, mood changes, or light breakthrough bleeding between periods may occur.
Less commonly: weight gain, reduced libido, irritability, or digestive disturbances.

Serious but rare side effects include deep vein thrombosis or pulmonary embolism. Seek immediate medical attention if you experience leg pain, sudden shortness of breath, or chest pain.

Levonorgestrel / Ethinylestradiol carries certain risks that users should be aware of. The use of combined hormonal contraceptives may increase the risk of blood clots, particularly in smokers or women with a family history of clotting disorders. Users who experience chest pain, sudden shortness of breath, or unusual headaches should seek medical advice immediately.

This medicine may also affect blood pressure and should be used with caution in women with a history of cardiovascular disease. Women who are pregnant or breastfeeding should not use this pill. Always consult a healthcare professional before starting or restarting treatment.